| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 3.42B | 15.17% |
| Operating expense | — | — |
| Net income | 1.08B | 18.41% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, C1P.F returned +76.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +16.4% |
| 1 year | +76.2% |
| 5 years | +21552.6% |
| 10 years | +193675.7% |
| All-time high | €1.87 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in C1P.F would be worth today ›Yes. Consun Pharmaceutical Group Limited paid 2 dividends over the past 12 months. The most recent was €0.04 per share on Jun 9, 2026. The dividend yield is 6.32%.
Consun Pharmaceutical Group Limited is part of the Healthcare sector.
Consun Pharmaceutical Group Limited has a market cap of 1.18B EUR, based on the latest quote.